Published in Nat Rev Cardiol on September 20, 2011
Metabolic phenotyping in clinical and surgical environments. Nature (2012) 2.09
Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS One (2015) 1.55
The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med (2015) 1.33
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation (2015) 1.25
Biomarkers intersect with the exposome. Biomarkers (2012) 1.22
Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem (2012) 1.11
Can NMR solve some significant challenges in metabolomics? J Magn Reson (2015) 0.98
Targeted lipidomics in Drosophila melanogaster identifies novel 2-monoacylglycerols and N-acyl amides. PLoS One (2013) 0.97
Translating metabolomics to cardiovascular biomarkers. Prog Cardiovasc Dis (2012) 0.92
Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal Bioanal Chem (2015) 0.91
Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. Genet Epidemiol (2013) 0.89
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med (2015) 0.85
The Time Is Right to Focus on Model Organism Metabolomes. Metabolites (2016) 0.84
In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy. J Cardiovasc Magn Reson (2013) 0.83
The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis (2014) 0.83
Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int (2013) 0.83
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.82
Plasma amino acid profiling identifies specific amino acid associations with cardiovascular function in patients with systolic heart failure. PLoS One (2015) 0.82
Plasma Metabolic Profile Determination in Young ST-segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra-performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis. Chin Med J (Engl) (2016) 0.82
Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLoS One (2014) 0.80
Diastolic Left Ventricular Function in Relation to Circulating Metabolic Biomarkers in a General Population. J Am Heart Assoc (2016) 0.79
An Evidence-Based Review of Related Metabolites and Metabolic Network Research on Cerebral Ischemia. Oxid Med Cell Longev (2016) 0.79
Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev (2014) 0.78
Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients. Europace (2015) 0.78
The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial. Eur J Cardiothorac Surg (2014) 0.78
Metabolomics-identified metabolites associated with body mass index and prospective weight gain among Mexican American women. Obes Sci Pract (2016) 0.78
Biomarker Discovery and Translation in Metabolomics. Curr Metabolomics (2016) 0.77
Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure. J Card Fail (2015) 0.76
Metabolomic approach to profile functional and metabolic changes in heart failure. J Transl Med (2015) 0.76
The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy. PLoS One (2015) 0.76
A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy. Metabolomics (2016) 0.76
Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage. Anal Chem (2015) 0.76
High-Throughput Metabolic Profiling of Soybean Leaves by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. Anal Chem (2015) 0.75
Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia. PLoS One (2014) 0.75
Lipidomics in vascular health: current perspectives. Vasc Health Risk Manag (2015) 0.75
Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. Oncotarget (2016) 0.75
Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial. BMC Complement Altern Med (2016) 0.75
Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients. PLoS One (2016) 0.75
Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia. Sci Rep (2016) 0.75
Technology platform development for targeted plasma metabolites in human heart failure. Clin Proteomics (2013) 0.75
A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction. Sci Rep (2016) 0.75
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. Int J Epidemiol (2016) 0.75
Proteomics, and metabolomics: magnetic resonance spectroscopy for the presurgical screening of thyroid nodules. Curr Genomics (2014) 0.75
Metabolomics As a Tool for the Characterization of Drug-Resistant Epilepsy. Front Neurol (2017) 0.75
Metabolic Biomarkers in Heart Failure. Heart Fail Clin (2018) 0.75
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine. Biomed Res Int (2017) 0.75
Changes in the mitochondrial function and in the efficiency of energy transfer pathways during cardiomyocyte aging. Mol Cell Biochem (2017) 0.75
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Electrospray ionization for mass spectrometry of large biomolecules. Science (1989) 16.50
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
Metabolite profiling for plant functional genomics. Nat Biotechnol (2000) 8.74
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol (1995) 7.12
Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev (2005) 5.98
Systematic functional analysis of the yeast genome. Trends Biotechnol (1998) 5.69
Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet (2008) 5.23
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol (2004) 5.01
The emerging field of lipidomics. Nat Rev Drug Discov (2005) 4.69
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation (2007) 3.88
Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation (2005) 3.16
Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A (2007) 3.15
Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia (2009) 2.63
Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev (2010) 2.50
Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest (2008) 2.46
Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study. PLoS One (2007) 2.38
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res (2002) 2.30
Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol (2010) 2.17
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res (2008) 2.15
Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J (2009) 2.05
A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS One (2006) 2.01
Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis. J Bacteriol (1998) 1.94
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol (2007) 1.80
Activity of phosphorylase in total global ischaemia in the rat heart. A phosphorus-31 nuclear-magnetic-resonance study. Biochem J (1981) 1.65
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst (2003) 1.65
The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc Lond B Biol Sci (2006) 1.63
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation (2007) 1.59
Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry (2005) 1.59
Lipidomics and lipid profiling in metabolomics. Curr Opin Lipidol (2007) 1.58
Phosphorus nuclear magnetic resonance studies on normoxic and ischemic cardiac tissue. Proc Natl Acad Sci U S A (1976) 1.57
Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3-. Magn Reson Med (2008) 1.52
Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes (2010) 1.52
Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics (2007) 1.51
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Detection of cerebral lactate in vivo during hypoxemia by 1H NMR at relatively low field strengths (1.9 T). Proc Natl Acad Sci U S A (1984) 1.51
Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med (2006) 1.49
Mechanism of early contractile failure during hypoxia in intact ferret heart: evidence for modulation of maximal Ca2+-activated force by inorganic phosphate. Circ Res (1986) 1.46
Adenosine triphosphate compartmentation in living hearts: a phosphorus nuclear magnetic resonance saturation transfer study. Biochemistry (1979) 1.45
DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res (2010) 1.36
A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics (2006) 1.34
The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol (2007) 1.30
Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization. J Lipid Res (2005) 1.28
Pyruvate dehydrogenase influences postischemic heart function. Circulation (1995) 1.26
Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol (2005) 1.23
Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics. Biochemistry (2005) 1.23
Studies of metabolism in the isolated, perfused rat heart using 13C NMR. FEBS Lett (1981) 1.22
Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol Syst Biol (2009) 1.18
Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol Endocrinol Metab (2005) 1.16
Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol Biosyst (2009) 1.15
In vivo carbon-13 nuclear magnetic resonance studies of heart metabolism. Proc Natl Acad Sci U S A (1983) 1.15
Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol (2007) 1.15
Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13
Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol (2008) 1.13
Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J Chromatogr A (2005) 1.10
Towards the plant metabolome and beyond. Nat Rev Mol Cell Biol (2007) 1.08
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol (2009) 1.05
N.m.r. studies of metabolism in perfused organs. Philos Trans R Soc Lond B Biol Sci (1980) 1.00
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation. Mol Cell Biochem (2008) 0.98
Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy. Magn Reson Med (2001) 0.97
Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Invest (2010) 0.97
Metabolomic study of the LDL receptor null mouse fed a high-fat diet reveals profound perturbations in choline metabolism that are shared with ApoE null mice. Physiol Genomics (2010) 0.97
Metabolic remodeling in the aging heart. J Mol Cell Cardiol (2005) 0.96
Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse. Genome Med (2009) 0.94
Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein. NMR Biomed (2009) 0.94
1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters. Atherosclerosis (2009) 0.94
Altered metabolite exchange between subcellular compartments in intact postischemic rabbit hearts. Circ Res (1997) 0.93
Metabolomics and atherosclerosis. Curr Atheroscler Rep (2010) 0.93
Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed (1998) 0.93
Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem (2001) 0.92
Reduced substrate oxidation in postischemic myocardium: 13C and 31P NMR analyses. Am J Physiol (1990) 0.91
Metabolomic strategies to study lipotoxicity in cardiovascular disease. Biochim Biophys Acta (2009) 0.91
ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit. Hum Mol Genet (2006) 0.91
Postnatal expression and activity of the mitochondrial 2-oxoglutarate-malate carrier in intact hearts. Am J Physiol Cell Physiol (2000) 0.90
Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis. Mol Biosyst (2010) 0.90
Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat Rec (1998) 0.89
An introduction to biological nuclear magnetic resonance spectroscopy. Biol Rev Camb Philos Soc (2010) 0.89
A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J Proteome Res (2008) 0.88
Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. J Proteome Res (2009) 0.87
Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes. Cardiovasc Res (1999) 0.87
Changes of organic acids in rat heart muscle under ischemic-like conditions. J Chromatogr (1982) 0.87
Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed (2009) 0.87
Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome. Genome Med (2009) 0.87
The role of intracellular [Ca2+] and [H+] in contractile failure of the hypoxic heart. Adv Myocardiol (1985) 0.87
Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics (2007) 0.86
Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis. Circ Cardiovasc Imaging (2010) 0.86
Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation (2002) 0.85
Metabolomics in angiotensin II-induced cardiac hypertrophy. Hypertension (2010) 0.84
Creatine kinase kinetics in diabetic cardiomyopathy. Am J Physiol (1995) 0.84
Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett (2002) 0.84
Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts. Am J Physiol Heart Circ Physiol (2008) 0.83
A stable isotope technique for investigating lactate metabolism in humans. Biomed Mass Spectrom (1983) 0.81
Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase or deferoxamine. A 31P nuclear resonance study. Circulation (1988) 0.79
Deployment of distributed applications in wireless sensor networks. Sensors (Basel) (2011) 3.53
Use of email for consulting with patients in general practice. Br J Gen Pract (2013) 2.62
Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc (2010) 2.18
Evidence of effectiveness of health care professionals using handheld computers: a scoping review of systematic reviews. J Med Internet Res (2013) 1.69
Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis (2010) 1.43
A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics (2006) 1.34
Use of handheld computers in clinical practice: a systematic review. BMC Med Inform Decis Mak (2014) 1.19
Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc (2012) 1.13
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res (2011) 1.07
Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med (2011) 1.07
Are there enough GPs in England to detect hypertension and maintain access? Br J Gen Pract (2013) 1.06
Patient use of email for health care communication purposes across 14 European countries: an analysis of users according to demographic and health-related factors. J Med Internet Res (2015) 1.05
Email for the provision of information on disease prevention and health promotion. Cochrane Database Syst Rev (2012) 1.00
Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials (2008) 1.00
An information revolution: time for the NHS to step up to the challenge. J R Soc Med (2011) 0.98
Metabolomics application in maternal-fetal medicine. Biomed Res Int (2013) 0.98
Recruiting young women to a trial of chlamydia screening. Int J STD AIDS (2006) 0.93
A metabolomic study of preterm human and formula milk by high resolution NMR and GC/MS analysis: preliminary results. J Matern Fetal Neonatal Med (2012) 0.91
Metabolomics: a new era in cardiology? J Cardiovasc Med (Hagerstown) (2011) 0.90
BARD1: an independent predictor of survival in non-small cell lung cancer. Int J Cancer (2011) 0.88
Normobaric hypoxia impairs human cardiac energetics. FASEB J (2011) 0.88
omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics (2009) 0.88
Clinical application of metabolomics in neonatology. J Matern Fetal Neonatal Med (2012) 0.87
An appraisal of the literature on teaching physical examination skills. Educ Prim Care (2012) 0.84
Email for communicating results of diagnostic medical investigations to patients. Cochrane Database Syst Rev (2012) 0.84
Pharmaceutical research and metabolomics in the newborn. J Matern Fetal Neonatal Med (2012) 0.84
Use of opt-out in a trial of chlamydia screening. Int J STD AIDS (2008) 0.83
Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann N Y Acad Sci (2013) 0.83
Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. J Matern Fetal Neonatal Med (2011) 0.83
Metabolomics in the developing human being. Pediatr Clin North Am (2012) 0.82
Email for clinical communication between healthcare professionals. Cochrane Database Syst Rev (2015) 0.82
Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease. J Matern Fetal Neonatal Med (2014) 0.81
Email for clinical communication between healthcare professionals. Cochrane Database Syst Rev (2012) 0.81
Social networking and health. Lancet (2011) 0.81
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study. PLoS One (2013) 0.81
Pharma-metabolomics in neonatology: is it a dream or a fact? Curr Pharm Des (2012) 0.80
Urinary metabolomics in newborns and infants. Adv Clin Chem (2012) 0.80
Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med (2011) 0.80
Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. Early Hum Dev (2013) 0.79
Using alternatives to face-to-face consultations: a survey of prevalence and attitudes in general practice. Br J Gen Pract (2016) 0.79
Metabolomics in the developing infant. Curr Opin Pediatr (2013) 0.78
Metabolomics in paediatric oncology: a potential still to be exploited. J Matern Fetal Neonatal Med (2013) 0.78
Editorial for the directed issue: "Metabolic pathways in cancer". Int J Biochem Cell Biol (2011) 0.77
Metabolomics: a new tool for the investigation of metabolic changes induced by cytomegalovirus. J Matern Fetal Neonatal Med (2013) 0.77
Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis. Int J STD AIDS (2008) 0.75
Metabolomics applied in neonatology. Bioanalysis (2014) 0.75
Metabolomics in neonatal life. Early Hum Dev (2013) 0.75
Sexual health services: a third way? Int J STD AIDS (2006) 0.75
Author's response. Br J Gen Pract (2013) 0.75
Delineating novel metabolic pathways of DPC 963, a non-nucleoside reverse transcriptase inhibitor, in rats. Characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC/MS and LC/NMR. Chem Res Toxicol (2002) 0.75
Robust methods are needed to investigate association between white rice consumption and type 2 diabetes. BMJ (2012) 0.75
In vivo isotopically labeled atherosclerotic aorta plaques in ApoE KO mice and molecular profiling by matrix-assisted laser desorption/ionization mass spectrometric imaging. Rapid Commun Mass Spectrom (2014) 0.75
1H NMR metabolite fingerprinting as a new tool for body fluid identification in forensic science. Magn Reson Chem (2013) 0.75
Accuracy of online health information about controlling childhood fever during the H1N1 influenza pandemic. Inform Prim Care (2009) 0.75
Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland. Eur J Intern Med (2008) 0.75
High meat consumption is associated with type 1 diabetes mellitus in a Sardinian case-control study. Acta Diabetol (2012) 0.75
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach. J Matern Fetal Neonatal Med (2014) 0.75